As part of its plans to grow niche contrast media products business, JB Chemicals & Pharmaceuticals Ltd. (JBCPL) has launched Definity vial, an ultrasound contrast imaging product in India under exclusive marketing arrangement with Lantheus Medical Imaging, Inc. USA, a leading diagnostic medical imaging products company. Definity is currently marketed in North America, Australia and New Zealand, parts of the Pacific Rim and several countries in the Middle East.
Top Section
Explore Business Standard